Search Within

Efsevia Vakiani

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (43)
  2. Meeting Abstract (41)
Groups
  1. Department of Pathology and Laboratory Medicine (84)
  2. Population Sciences Research Program (84)
  3. Department of Medicine (82)
  4. Solid Tumor Oncology Division (82)
  5. Center for Pancreatic Cancer Research (79)
  6. Surgery (77)

More Groups

People
  1. Jinru Shia (64)
  2. Zsofia Stadler (62)
  3. Martin Weiser (50)
  4. David Klimstra (36)
  5. Jaclyn Hechtman (31)
  6. Andrea Cercek Hanjis (26)

More People

Years
  1. 2025 (4)
  2. 2024 (1)
  3. 2023 (4)
  4. 2022 (8)
  5. 2021 (9)
  6. 2020 (5)

More Years

Publications
  1. Modern Pathology (18)
  2. Laboratory Investigation (15)
  3. Journal of Clinical Oncology (11)
  4. Clinical Cancer Research (6)
  5. Familial Cancer (5)
  6. Cancer (3)

More Publications

Publishers
  1. Nature Publishing Group (19)
  2. Nature Research (18)
  3. American Society of Clinical Oncology (12)
  4. American Association for Cancer Research (8)
  5. Springer (7)
  6. Oxford University Press (5)

More Publishers

Results (84)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Expression of PD-L1 in colorectal carcinoma (CRC) primarily occurs in stromal/immune cells at tumor-stroma interface (TSI), and is associated with high tumor-infiltrating lymphocytes (TILs) irrespective of the microsatellite instability (MSI) status or the molecular mechanism of MSI
    Meeting Abstract

    Liu, S.; Hechtman, J.; Segal, N.; Smith, J.; Rao, D.; Markowitz, A.; Weiser, M.; Vakiani, E.; Klimstra, D. S.; Stadler, Z.; more...
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Morphological characterization of colorectal cancers in the Cancer Genome Atlas reveals distinct morphology-molecular associations: Clinical and biological implications
    Journal Article

    Shia, J.; Schultz, N.; Kuk, D.; Vakiani, E.; Middha, S.; Segal, N. H.; Hechtman, J. F.; Berger, M. F.; Stadler, Z. K.; Weiser, M. R.; more...
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Expression of PD-L1 in colorectal carcinoma (CRC) primarily occurs in stromal/immune cells at tumor-stroma interface (TSI), and is associated with high tumor-infiltrating lymphocytes (TILs) irrespective of the microsatellite instability (MSI) status or the molecular mechanism of MSI
    Meeting Abstract

    Liu, S.; Hechtman, J.; Segal, N.; Smith, J.; Rao, D.; Markowitz, A.; Weiser, M.; Vakiani, E.; Klimstra, D. S.; Stadler, Z.; more...
    Laboratory Investigation (2017)

    Fulltext@MSK | Save
  • Clinical and genetic determinants of ovarian metastases from colorectal cancer
    Journal Article

    Ganesh, K.; Shah, R. H.; Vakiani, E.; Nash, G. M.; Skottowe, H. P.; Yaeger, R.; Cercek, A.; Lincoln, A.; Tran, C.; Segal, N. H.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Diagnosing colorectal medullary carcinoma: Interobserver variability and clinicopathological implications
    Journal Article

    Lee, L. H.; Yantiss, R. K.; Sadot, E.; Ren, B.; Calvacanti, M. S.; Hechtman, J. F.; Ivelja, S.; Huynh, B.; Xue, Y.; Shitilbans, T.; more...
    Human Pathology (2017)

    Fulltext@MSK | Save
  • Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases
    Journal Article

    Frankel, T. L.; Vakiani, E.; Nathan, H.; DeMatteo, R. P.; Kingham, T. P.; Allen, P. J.; Jarnagin, W. R.; Kemeny, N. E.; Solit, D. B.; D'Angelica, M. I.
    Cancer (2017)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
    Journal Article

    Lee, L. H.; Cavalcanti, M. S.; Segal, N. H.; Hechtman, J. F.; Weiser, M. R.; Smith, J. J.; Garcia-Aguilar, J.; Sadot, E.; Ntiamoah, P.; Markowitz, A. J.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Clinical prognostic factors and genomic analysis of ovary metastases (mets) from colorectal cancer (CRC)
    Meeting Abstract

    Ganesh, K.; Shah, R.; Vakiani, E.; Kemeny, N. E.; Lincoln, A.; Tran, C.; Varghese, A. M.; Yaeger, R. D.; Cercek, A.; Segal, N. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save